HISTORY

The UCLA Institute for Stem Cell Biology and Medicine was launched by then Chancellor Carnesale and the Deans of the UCLA Schools and College in March 2005, with a UCLA commitment of $20 million over five years.

Allocated resources include recruitment of 12 new faculty. The Co-Directors of ISCBM are Owen Witte, MD, Judith Gasson, PhD, Utpal Banerjee, PhD.

In recognition of a generous gift, the Institute was renamed the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA in September 2007.

SInce 2005, UCLA Broad Stem Cell Center (BSCC) scientists have received:

• 1 NIH Innovator Award
  
  
• 9 California Institute for Regenerative Medicine (CIRM) [Proposition 71] Seed & Comprehensive Grants to study:
  - HIV                                   - Melanoma
  -  Neural Repair               -  Blood Development
  -  Immune Response     -  Differentiation, self-renewal, & Epigenetics
  
  
• $3.75M CIRM Training Grant

• $2.8M CIRM Shared Research Laboratory Grant

UNIQUE COLLABORATION

UCLA possesses unique strengths that will position the Center as a leader in the field

• Close ongoing collaboration across the university’s scientific, medical and academic disciplines, including:
  • Jonsson Comprehensive Cancer Center (JCCC)
  • AIDS Institute, including the Center for Clinical AIDS Research and Education
  • UCLA Center for Society and Genetics
  • Brain Research Institute (BRI)
  • California NanoSystems Institute (CNSI)
  • College of Letters and Science, Schools of Engineering, Medicine, Law, Nursing, Dentistry, & Public Affairs
• Strong history of translational research bringing research from the laboratory to the bedside, in breast, lung, and colon cancer, leukemia, and gene medicine

FACILITIES

Investigators and staff from the various academic and scientific disciplines are steps away from each other on-campus (a little more than half a square mile). The close proximity of diverse disciplines facilitates communication and collaboration. Our Campus also includes the benefits of the FDA compliant Good Manufacturing Practice (GMP) facilities which facilitate translational research to the clinic, as well as the UCLA Medical Center, ranked #1 in California and in the West and #5 in the nation by U.S. News & World Report.

UCLA South Campus Science and Medical Cluster, July 2004